Clinical trial

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

NCT02347059

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE2

Study timeline

Study start (unknown)2015-01-01Date precision: month

Registry last updated2015-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

L-dopaDRUG

Dopamine Agonists (pramipexole, ropirinole)DRUG

Sponsors & collaborators

University of Torontolead sponsor

Michael J. Fox Foundation for Parkinson's Researchcollaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02347059 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.